| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACETAMINOPHEN AND IBUPROFEN | 214836 | 001 | ANDA | ACETAMINOPHEN; IBUPROFEN | TABLET;ORAL | 250MG;125MG | No | No | 2023/02/28 | 2023/02/28 | L PERRIGO CO | Over-the-counter |
| ACETAMINOPHEN AND IBUPROFEN | 216994 | 001 | ANDA | ACETAMINOPHEN; IBUPROFEN | TABLET;ORAL | 250MG;125MG | No | No | 2023/07/10 | 2023/07/10 | MARKSANS PHARMA | Over-the-counter |
| ACETAMINOPHEN AND IBUPROFEN | 216592 | 001 | ANDA | ACETAMINOPHEN; IBUPROFEN | TABLET;ORAL | 250MG;125MG | No | No | 2023/07/13 | 2023/07/13 | GRANULES | Over-the-counter |
| ACETAMINOPHEN AND IBUPROFEN | 216999 | 001 | ANDA | ACETAMINOPHEN; IBUPROFEN | TABLET;ORAL | 250MG;125MG | No | No | 2023/08/01 | 2023/08/01 | BIONPHARMA | Over-the-counter |
| ACETAMINOPHEN AND IBUPROFEN | 218359 | 001 | ANDA | ACETAMINOPHEN; IBUPROFEN | TABLET;ORAL | 250MG;125MG | No | No | 2024/03/26 | 2024/03/26 | AUROBINDO PHARMA LTD | Discontinued |
| ACETAMINOPHEN AND IBUPROFEN | 218311 | 001 | ANDA | ACETAMINOPHEN; IBUPROFEN | TABLET;ORAL | 250MG;125MG | No | No | 2024/04/26 | 2024/04/26 | GLENMARK PHARMS LTD | Over-the-counter |
| ACETAMINOPHEN AND IBUPROFEN | 218247 | 001 | ANDA | ACETAMINOPHEN; IBUPROFEN | TABLET;ORAL | 250MG;125MG | No | No | 2024/08/23 | 2024/08/23 | DR REDDYS | Over-the-counter |